216 related articles for article (PubMed ID: 22367096)
1. Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts.
Brown M; Postlethwaite AE; Myers LK; Hasty KA
Clin Rheumatol; 2012 Jun; 31(6):973-81. PubMed ID: 22367096
[TBL] [Abstract][Full Text] [Related]
2. Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.
Brembilla NC; Montanari E; Truchetet ME; Raschi E; Meroni P; Chizzolini C
Arthritis Res Ther; 2013 Oct; 15(5):R151. PubMed ID: 24289089
[TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
4. Chronic exposure of interleukin-13 suppress the induction of matrix metalloproteinase-1 by tumour necrosis factor α in normal and scleroderma dermal fibroblasts through protein kinase B/Akt.
Brown Lobbins ML; Shivakumar BR; Postlethwaite AE; Hasty KA
Clin Exp Immunol; 2018 Jan; 191(1):84-95. PubMed ID: 28884475
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway.
Sambo P; Baroni SS; Luchetti M; Paroncini P; Dusi S; Orlandini G; Gabrielli A
Arthritis Rheum; 2001 Nov; 44(11):2653-64. PubMed ID: 11710721
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
Distler O; Pap T; Kowal-Bielecka O; Meyringer R; Guiducci S; Landthaler M; Schölmerich J; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Müller-Ladner U
Arthritis Rheum; 2001 Nov; 44(11):2665-78. PubMed ID: 11710722
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
[TBL] [Abstract][Full Text] [Related]
8. CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
Shimada S; Makino K; Jinnin M; Sawamura S; Kawano Y; Ide M; Kajihara I; Makino T; Fukushima S; Ihn H
J Dermatol Sci; 2020 Dec; 100(3):183-191. PubMed ID: 33055012
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts.
Hügle T; O'Reilly S; Simpson R; Kraaij MD; Bigley V; Collin M; Krippner-Heidenreich A; van Laar JM
Arthritis Rheum; 2013 Feb; 65(2):481-91. PubMed ID: 23045159
[TBL] [Abstract][Full Text] [Related]
10. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
[TBL] [Abstract][Full Text] [Related]
11. Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.
Fineschi S; Cozzi F; Burger D; Dayer JM; Meroni PL; Chizzolini C
Rheumatology (Oxford); 2007 Dec; 46(12):1779-85. PubMed ID: 17982166
[TBL] [Abstract][Full Text] [Related]
12. CXCL4 triggers monocytes and macrophages to produce PDGF-BB, culminating in fibroblast activation: Implications for systemic sclerosis.
van der Kroef M; Carvalheiro T; Rossato M; de Wit F; Cossu M; Chouri E; Wichers CGK; Bekker CPJ; Beretta L; Vazirpanah N; Trombetta E; Radstake TRDJ; Angiolilli C
J Autoimmun; 2020 Jul; 111():102444. PubMed ID: 32284212
[TBL] [Abstract][Full Text] [Related]
13. Anti-fibrotic characteristics of Vγ9+ γδ T cells in systemic sclerosis.
Markovits N; Bendersky A; Loebstein R; Brusel M; Kessler E; Bank I
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):23-29. PubMed ID: 26886502
[TBL] [Abstract][Full Text] [Related]
14. Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts.
Tsou PS; Balogh B; Pinney AJ; Zakhem G; Lozier A; Amin MA; Stinson WA; Schiopu E; Khanna D; Fox DA; Koch AE
Arthritis Res Ther; 2014; 16(5):411. PubMed ID: 25123250
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic effects of hepatocyte growth factor on scleroderma fibroblasts and analysis of its mechanism.
Sherriff-Tadano R; Ohta A; Morito F; Mitamura M; Haruta Y; Koarada S; Tada Y; Nagasawa K; Ozaki I
Mod Rheumatol; 2006; 16(6):364-71. PubMed ID: 17164998
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast proliferation by bleomycin stimulated peripheral blood mononuclear cell factors.
Yamamoto T; Katayama I; Nishioka K
J Rheumatol; 1999 Mar; 26(3):609-15. PubMed ID: 10090171
[TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1.
Bujor AM; Haines P; Padilla C; Christmann RB; Junie M; Sampaio-Barros PD; Lafyatis R; Trojanowska M
Int J Mol Med; 2012 Dec; 30(6):1473-80. PubMed ID: 23041765
[TBL] [Abstract][Full Text] [Related]
18. Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts.
Tsou PS; Talia NN; Pinney AJ; Kendzicky A; Piera-Velazquez S; Jimenez SA; Seibold JR; Phillips K; Koch AE
Arthritis Rheum; 2012 Jun; 64(6):1978-89. PubMed ID: 22161819
[TBL] [Abstract][Full Text] [Related]
19. Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor.
Takemura H; Suzuki H; Fujisawa H; Yuhara T; Akama T; Yamane K; Kashiwagi H
J Rheumatol; 1998 Aug; 25(8):1534-9. PubMed ID: 9712097
[TBL] [Abstract][Full Text] [Related]
20. Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts.
Tamaki Z; Asano Y; Kubo M; Ihn H; Tada Y; Sugaya M; Kadono T; Sato S
J Dermatol Sci; 2014 Jun; 74(3):251-9. PubMed ID: 24630239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]